Amundi Asset Management US’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $187K | Hold |
4,600
| – | – | ﹤0.01% | 1453 |
|
|
2020
Q4 | $199K | Hold |
4,600
| – | – | ﹤0.01% | 1396 |
|
|
2020
Q3 | $254K | Hold |
4,600
| – | – | ﹤0.01% | 1343 |
|
|
2020
Q2 | $290K | Hold |
4,600
| – | – | ﹤0.01% | 1317 |
|
|
2020
Q1 | $235K | Hold |
4,600
| – | – | ﹤0.01% | 1294 |
|
|
2019
Q4 | $366K | Hold |
4,600
| – | – | ﹤0.01% | 1359 |
|
|
2019
Q3 | $223K | Buy |
4,600
+1,000
| +28% | +$48.5K | ﹤0.01% | 1418 |
|
|
2019
Q2 | $189K | Hold |
3,600
| – | – | ﹤0.01% | 1458 |
|
|
2019
Q1 | $191K | Hold |
3,600
| – | – | ﹤0.01% | 1419 |
|
|
2018
Q4 | $148 | Buy |
+3,600
| New | +$148 | ﹤0.01% | 1415 |
|
|
2018
Q3 | – | Sell |
-11,100
| Closed | -$502K | – | 1621 |
|
|
2018
Q2 | $502K | Sell |
11,100
-200
| -2% | -$9.05K | ﹤0.01% | 1340 |
|
|
2018
Q1 | $546K | Sell |
11,300
-52,200
| -82% | -$2.52M | ﹤0.01% | 1267 |
|
|
2017
Q4 | $2.5M | Buy |
+63,500
| New | +$2.5M | ﹤0.01% | 1026 |
|